Literature DB >> 9891598

Apoptosis in the failing heart.

J Narula1, R J Hajjar, G W Dec.   

Abstract

Apoptosis is a tightly regulated, energy-requiring process of programmed cell death. While necrosis is a form of cell death that results from acute cellular injury, apoptosis is controlled autodigestion of the cell that occurs through activation of endogenous proteases. This process results in the cleavage of chromatin into oligonucleosome-length DNA fragments and its multiples. This DNA fragmentation demonstrates a characteristic laddering pattern on DNA agarose gel electrophoresis. The heart undergoes extensive remodeling during embryogenesis wherein apoptosis significantly contributes to the development of the cardiac chambers and correct routing of the great vessels. Pathologic stimuli can also result in apoptosis and include ischemia, hypoxia, inflammation, cytokines, growth factors, and toxic agents. Better understanding of the molecular mechanisms responsible for regulating apoptosis in the failing myocardium may soon lead to strategies aimed at preventing further myocyte loss and enhancing myocyte replacement through regulated cell growth.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9891598     DOI: 10.1016/s0733-8651(05)70045-x

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  18 in total

1.  Low-intensity aerobic interval training attenuates pathological left ventricular remodeling and mitochondrial dysfunction in aortic-banded miniature swine.

Authors:  Craig A Emter; Christopher P Baines
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-03       Impact factor: 4.733

2.  BNIP3 promotes calcium and calpain-dependent cell death.

Authors:  Regina M Graham; John W Thompson; Keith A Webster
Journal:  Life Sci       Date:  2015-10-21       Impact factor: 5.037

3.  Comparison of heart failure in children with enterovirus 71 rhombencephalitis and cats with norepinephrine cardiotoxicity.

Authors:  Y-C Fu; C-S Chi; N-N Lin; C-C Cheng; S-L Jan; B Hwang; S-L Hsu; C-L Gong; Y-T Chen; Y-T Chiu
Journal:  Pediatr Cardiol       Date:  2006 Sep-Oct       Impact factor: 1.655

Review 4.  In vivo detection of apoptotic cell death: a necessary measurement for evaluating therapy for myocarditis, ischemia, and heart failure.

Authors:  F Blankenberg; J Narula; H W Strauss
Journal:  J Nucl Cardiol       Date:  1999 Sep-Oct       Impact factor: 5.952

5.  Vascular endothelial growth factor prevents apoptosis and preserves contractile function in hypertrophied infant heart.

Authors:  Ingeborg Friehs; Rodrigo Barillas; Nikolay V Vasilyev; Nathalie Roy; Francis X McGowan; Pedro J del Nido
Journal:  Circulation       Date:  2006-07-04       Impact factor: 29.690

6.  Exercise training improves systolic function in hypertensive myocardium.

Authors:  Joseph R Libonati; Abdelkarim Sabri; Canhua Xiao; Scott M Macdonnell; Brian F Renna
Journal:  J Appl Physiol (1985)       Date:  2011-09-15

7.  Nitric oxide and promotion of cardiac myocyte apoptosis.

Authors:  Péter Andréka; Thanh Tran; Keith A Webster; Nanette H Bishopric
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

8.  Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3.

Authors:  Lori A Kubasiak; Olga M Hernandez; Nanette H Bishopric; Keith A Webster
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-11       Impact factor: 11.205

9.  MicroRNA-125b protects against myocardial ischaemia/reperfusion injury via targeting p53-mediated apoptotic signalling and TRAF6.

Authors:  Xiaohui Wang; Tuanzhu Ha; Jianghuan Zou; Danyang Ren; Li Liu; Xia Zhang; John Kalbfleisch; Xiang Gao; David Williams; Chuanfu Li
Journal:  Cardiovasc Res       Date:  2014-02-27       Impact factor: 10.787

10.  Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury.

Authors:  Xiaohui Wang; Tuanzhu Ha; Li Liu; Jianghuan Zou; Xia Zhang; John Kalbfleisch; Xiang Gao; David Williams; Chuanfu Li
Journal:  Cardiovasc Res       Date:  2012-12-03       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.